id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S10075 R36693 |
Coste (Carbamazepine), 2020 | Weight at birth <2500 g | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | exposed to other treatment, sick | Adjustment: No | 1.34 [0.75;2.37] C | 14/176 128/2,108 | 142 | 176 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5925 R15072 |
Artama (Carbamazepine) (Controls exposed to Lamotrigine, sick), 2013 | Low birth weight (< 2500g) | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
1.38 [0.58;3.27] C excluded (control group) |
51/1,077 6/173 | 57 | 1,077 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5909 R14887 |
Artama (Carbamazepine) (Controls unexposed, disease free), 2013 | Low birth weight (< 2500g) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
1.63 [1.23;2.17] excluded (control group) |
51/1,077 21,546/719,509 | 21,597 | 1,077 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5917 R14983 |
Artama (Carbamazepine) (Controls unexposed, sick), 2013 | Low birth weight (< 2500g) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 1.31 [0.89;1.92] | 51/1,077 65/1,793 | 116 | 1,077 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6356 R21028 |
Veiby (Carbamazepine) (Controls exposed to Lamotrigine, sick) b, 2013 | Low birth weight (< 2500 grams) | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
1.30 [0.38;4.46] C excluded (control group) |
5/67 6/103 | 11 | 67 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6354 R17338 |
Veiby (Carbamazepine) (Controls unexposed, disease free) b, 2013 | Low birth weight (< 2500 grams) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: Yes |
1.80 [0.70;4.40] excluded (control group) |
5/67 5,024/106,899 | 5,029 | 67 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6355 R17334 |
Veiby (Carbamazepine) (Controls unexposed, sick) b, 2013 | Low birth weight (< 2500 grams) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 1.86 [0.66;5.27] C | 5/67 16/386 | 21 | 67 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S7181 R20253 |
Kini (Carbamazepine) (Controls unexposed, sick), 2006 | Birth weight <2500 g | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No | 0.27 [0.07;1.00] C | 3/94 11/101 | 14 | 94 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 4 studies | 1.16 [0.71;1.92] | 293 | 1,414 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Carbamazepine; 2: Carbamazepine) (Controls unexposed, sick; 3: Carbamazepine) (Controls unexposed, sick) ; 4: Carbamazepine) (Controls unexposed, sick;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded 5925, 5909, 6356, 6354